Skip to main content
Journal cover image

Gamma-radiation sensitivity and risk of glioma.

Publication ,  Journal Article
Bondy, ML; Wang, LE; El-Zein, R; de Andrade, M; Selvan, MS; Bruner, JM; Levin, VA; Alfred Yung, WK; Adatto, P; Wei, Q
Published in: J Natl Cancer Inst
October 17, 2001

BACKGROUND: About 9% of human cancers are brain tumors, of which 90% are gliomas. gamma-Radiation has been identified as a risk factor for brain tumors. In a previous pilot study, we found that lymphocytes from patients with glioma were more sensitive to gamma-radiation than were lymphocytes from matched control subjects. In this larger case-control study, we compared the gamma-radiation sensitivity of lymphocytes from glioma patients with those from control subjects and investigated the association between mutagen sensitivity and the risk for developing glioma. METHODS: We used a mutagen sensitivity assay (an indirect measure of DNA repair activity) to assess chromosomal damage. We gamma-irradiated (1.5 Gy) short-term lymphocyte cultures from 219 case patients with glioma and from 238 healthy control subjects frequency matched by age and sex. After irradiation, cells were cultured for 4 hours, and then Colcemid was added for 1 hour to arrest cells in mitosis. Fifty metaphases were randomly selected for each sample and scored for chromatid breaks. All statistical tests were two-sided. RESULTS: We observed a statistically significantly higher frequency of chromatid breaks per cell from case patients with glioma (mean = 0.55; 95% confidence interval [CI] = 0.50 to 0.59) than from control subjects (mean = 0.44; 95% CI = 0.41 to 0.48) (P<.001). Using 0.40 (the median number of chromatid breaks per cell in control subjects) as the cut point for defining mutagen sensitivity and adjusting for age, sex, and smoking status, we found that mutagen sensitivity was statistically significantly associated with an increased risk for glioma (odds ratio = 2.09; 95% CI = 1.43 to 3.06). When the data were divided into tertiles, the relative risk for glioma increased from the lowest tertile to the highest tertile (trend test, P<.001). CONCLUSION: gamma-Radiation-induced mutagen sensitivity of lymphocytes may be associated with an increased risk for glioma, a result that supports our earlier preliminary findings.

Duke Scholars

Published In

J Natl Cancer Inst

DOI

ISSN

0027-8874

Publication Date

October 17, 2001

Volume

93

Issue

20

Start / End Page

1553 / 1557

Location

United States

Related Subject Headings

  • Smoking
  • Risk
  • Radiation Tolerance
  • Oncology & Carcinogenesis
  • Odds Ratio
  • Neoplasms, Radiation-Induced
  • Middle Aged
  • Male
  • Lymphocytes
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bondy, M. L., Wang, L. E., El-Zein, R., de Andrade, M., Selvan, M. S., Bruner, J. M., … Wei, Q. (2001). Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst, 93(20), 1553–1557. https://doi.org/10.1093/jnci/93.20.1553
Bondy, M. L., L. E. Wang, R. El-Zein, M. de Andrade, M. S. Selvan, J. M. Bruner, V. A. Levin, W. K. Alfred Yung, P. Adatto, and Q. Wei. “Gamma-radiation sensitivity and risk of glioma.J Natl Cancer Inst 93, no. 20 (October 17, 2001): 1553–57. https://doi.org/10.1093/jnci/93.20.1553.
Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001 Oct 17;93(20):1553–7.
Bondy, M. L., et al. “Gamma-radiation sensitivity and risk of glioma.J Natl Cancer Inst, vol. 93, no. 20, Oct. 2001, pp. 1553–57. Pubmed, doi:10.1093/jnci/93.20.1553.
Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001 Oct 17;93(20):1553–1557.
Journal cover image

Published In

J Natl Cancer Inst

DOI

ISSN

0027-8874

Publication Date

October 17, 2001

Volume

93

Issue

20

Start / End Page

1553 / 1557

Location

United States

Related Subject Headings

  • Smoking
  • Risk
  • Radiation Tolerance
  • Oncology & Carcinogenesis
  • Odds Ratio
  • Neoplasms, Radiation-Induced
  • Middle Aged
  • Male
  • Lymphocytes
  • Humans